Pirow Bekker
- Oncology top 0.5%
- Molecular Biology top 5%
- Orthopedics and Sports Medicine top 0.2%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Donna HollowayThomas J. SchallDavid JayneColin R. DunstanPhilip T. LeesePeter A. MerkelStanley CohenMark Peterson
- Topics
- Bone health and treatments (22 papers)Vasculitis and related conditions (20 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Pirow Bekker
75 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 3.0k
- Molecular Biology 2.1k
- Orthopedics and Sports Medicine 1.6k
- Immunology 1.2k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Pirow Bekker
This map shows the geographic impact of Pirow Bekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pirow Bekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pirow Bekker more than expected).
Fields of papers citing papers by Pirow Bekker
This network shows the impact of papers produced by Pirow Bekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pirow Bekker. The network helps show where Pirow Bekker may publish in the future.
Co-authorship network of co-authors of Pirow Bekker
This figure shows the co-authorship network connecting the top 25 collaborators of Pirow Bekker. A scholar is included among the top collaborators of Pirow Bekker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pirow Bekker. Pirow Bekker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 46 | |
| 6 | Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitisbreakdown → | 420 |
| 7 | 115 | |
| 8 | 18 | |
| 9 | 220 | |
| 10 | Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis | 4 |
| 11 | 110 | |
| 12 | 76 | |
| 13 | 130 | |
| 14 | MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B | 1 |
| 15 | 1 | |
| 16 | 16 | |
| 17 | Denosumab in Postmenopausal Women with Low Bone Mineral Densitybreakdown → | 886 |
| 18 | 385 | |
| 19 | 13 | |
| 20 | 22 |
About Pirow Bekker
Pirow Bekker is a scholar working on Genetics, Oncology and Orthopedics and Sports Medicine, having authored 76 papers that have together received 5.8k indexed citations. Recurring topics across this work include Bone health and treatments (22 papers), Vasculitis and related conditions (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.6k citations), Oncology (3.0k citations) and Nephrology (648 citations). Pirow Bekker has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Donna Holloway, Thomas J. Schall, David Jayne, Colin R. Dunstan, Philip T. Leese, Peter A. Merkel, Stanley Cohen, Mark Peterson, Steven W. Martin and Paul D. Miller. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.